Similar Articles
1271 Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
1272 Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma
1273 Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma
1274 Hepatocellular carcinoma in patients with chronic kidney disease
1275 Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma
1276 Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
1277 Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?
1278 Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
1279 Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease
1280 Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA